Anson Funds Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-1,500,000
Closed -$540K – 82
2017
Q3
$540K Hold
1,500,000
– – 0.08% 50
2017
Q2
$570K Buy
1,500,000
+263,787
+21% +$108K 0.18% 33
2017
Q1
$556K Buy
+1,236,213
New +$543K 0.23% 29

Other funds holding GCVRZ

Anson Funds Management's GCVRZ Position: Q4 2017 in Review

Anson Funds Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2017, closing a stake of 1,500,000 shares — an estimated $540K sold.

Anson Funds Management first reported a position in GCVRZ in Q1 2017 and held it in 3 quarters. The position peaked at $570K in Q2 2017. 105 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2017.

  • Anson Funds Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2017 after selling out during the quarter.
  • Anson Funds Management sold 1,500,000 Sanofi Contingent Value Rights shares in Q4 2017, an estimated $540K.
  • Anson Funds Management first reported a position in Sanofi Contingent Value Rights in Q1 2017 and held it in 3 quarters.
  • Anson Funds Management's Sanofi Contingent Value Rights position peaked at $570K in Q2 2017.
  • 105 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2017.

Based on Anson Funds Management's 13F filing for Q4 2017, filed 14 Feb 2018.